Abzena, a U.K.-based pharma services company, appears to be on an acquisition tear of late, saying it plans to buy a second U.S.-based company in as many months.
U.K.-based Abzena raised some cash last year with an IPO. Now the pharma services company has taken some of its cash and shares and bought itself a U.S. manufacturing outpost in California.
DPx Buyout Of Specialty API Maker IRIX Is A Wrap